Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV immunoglobulin for painful sensory neuropathies in primary Sjögren's syndrome
2017-001371-24Phase 3Active
- Sponsor
- Strasbourg University Hospital
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in primary Sjögren's syndrome and peripheral neuropathy comparing IVIg with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2018; status: active.
02
Drugs
immune globulin
03
Conditions
primary Sjögren's syndromeperipheral neuropathy
Beyond the preview
Go deeper on 2017-001371-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001371-24.